Immediate Impact
51 standout
Citing Papers
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
2024 Standout
Works of Frederic Mack being referenced
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
2016
Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Frederic Mack | 264 | 162 | 119 | 12 | 368 | |
| Moritz Stuplich | 273 | 121 | 120 | 15 | 363 | |
| Michaelyn A. Page | 293 | 187 | 88 | 15 | 403 | |
| Nancy Riese | 212 | 161 | 117 | 11 | 344 | |
| Renate Haselmann | 141 | 209 | 84 | 9 | 343 | |
| Despina Misailidou | 266 | 178 | 93 | 9 | 401 | |
| Odom Gl | 255 | 141 | 68 | 10 | 363 | |
| Heinrich Elinzano | 263 | 100 | 119 | 18 | 369 | |
| Jean-Yves Delattre | 237 | 175 | 51 | 11 | 302 | |
| J.P. Bahary | 179 | 199 | 62 | 21 | 381 | |
| G Notter | 275 | 178 | 113 | 11 | 358 |
All Works
Login with ORCID to disown or claim papers
Loading papers...